American Association for the Advancement of Science, Science Immunology, 64(6), 2021
DOI: 10.1126/sciimmunol.abe7915
Full text: Unavailable
CD300a blockade ameliorates stroke pathology through enhancing efferocytosis in the brain by infiltrating myeloid cells.